Test Code: ONC003
Multiple endocrine Neoplasia (16 Genes) (includes MEN1/MEN2)
Oncogenetics
The Multiple Endocrine Neoplasia (MEN) Panel is a comprehensive genetic test designed to detect hereditary conditions that predispose individuals to endocrine tumours. This panel covers 16 clinically relevant genes associated with MEN1, MEN2A, MEN2B, and other hereditary endocrine neoplasia syndromes. These conditions increase the risk of tumours in the parathyroid glands, pituitary gland, pancreas, thyroid, adrenal glands, and other neuroendocrine tissues. Early genetic diagnosis enables personalised surveillance, targeted treatment, and informed family counselling.
Sample Type
Blood in EDTA; Bone marrow (Na Heparin Tube)
Turnaround Time
3 - 4 weeks days
Courier Requirements
Ship overnight at room temperature to receive next day. Maintain specimen at room temperature.
Pricing
Login to view pricing
Genes Analyzed
15 genes
AIP
CASR
CDC73
CDKN1B
MAX
MEN1
PRKAR1A
RET
SDHAF2
SDHB
SDHC
SDHD
TMEM127
TP53
VHL
Methodology
Capture-based target enrichment and Next Generation Sequencing.
Need Help with This Test?
Our team of board-certified genomic scientists is available to answer your questions about test selection, sample requirements, and result interpretation.